338
Views
13
CrossRef citations to date
0
Altmetric
Short Report

Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study

, , &
Pages 53-58 | Published online: 03 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Ilaria Ruffilli, Armando Patrizio, Gabriele Materazzi & Alessandro Antonelli. (2019) Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes. Cancer Management and Research 11, pages 7893-7907.
Read now
Poupak Fallahi, Silvia Martina Ferrari, Enke Baldini, Marco Biricotti, Salvatore Ulisse, Gabriele Materazzi, Paolo Miccoli & Alessandro Antonelli. (2016) The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer. Expert Review of Anticancer Therapy 16:11, pages 1109-1118.
Read now
Poupak Fallahi, Flavia Di Bari, Silvia Martina Ferrari, Roberto Spisni, Gabriele Materazzi, Paolo Miccoli, Salvatore Benvenga & Alessandro Antonelli. (2015) Selective use of vandetanib in the treatment of thyroid cancer. Drug Design, Development and Therapy 9, pages 3459-3470.
Read now
Louise Brygger & Jørn Herrstedt. (2014) 5-Hydroxytryptamine3 receptor antagonists and cardiac side effects. Expert Opinion on Drug Safety 13:10, pages 1407-1422.
Read now
Sheila A Doggrell & Jules C Hancox. (2013) Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia. Expert Opinion on Drug Safety 12:3, pages 421-431.
Read now

Articles from other publishers (8)

Sabaa Masarwe, Rachel Shvartsur, Eran Hadar, Batya Betesh-Abay, Noam Peleg & Abed N. Azab. (2023) Ondansetron Use During Pregnancy: Birth Defects and Obstetric Outcomes. Clinical Nursing Research 32:4, pages 705-711.
Crossref
Bora Lee, So Yeon Kim, Seung Hyun Kim, Hyukjin Yang, Jeong Hyun Jin & Seung Ho Choi. (2022) Heart-Rate-Corrected QT Interval Response to Ramosetron during Robot-Assisted Laparoscopic Prostatectomy: A Randomized Trial. Journal of Personalized Medicine 12:5, pages 811.
Crossref
А. М. Mudunov, Yu. V. Alymov, I. S. Romanov, S. О. Podvyaznikov & А. V. Ignatova. (2019) Efficacy of vandetanib in the treatment of medullary thyroid cancer: literature review and case report. Head and Neck Tumors (HNT) 9:3, pages 38-48.
Crossref
Efrat Rosenzweig Kean, Matthew Hinton & Clare Roepke. 2019. Gastrointestinal Emergencies. Gastrointestinal Emergencies 131 133 .
Jum-Suk Ko, Shuai Guo, Jonathan Hassel, Patricia Celestino-Soper, Ty C. Lynnes, James E. Tisdale, James J. Zheng, Stanley E. Taylor, Tatiana Foroud, Michael D. Murray, Richard J. Kovacs, Xiaochun Li, Shien-Fong Lin, Zhenhui Chen, Matteo Vatta, Peng-Sheng Chen & Michael Rubart. (2018) Ondansetron blocks wild-type and p.F503L variant small-conductance Ca 2+ -activated K + channels . American Journal of Physiology-Heart and Circulatory Physiology 315:2, pages H375-H388.
Crossref
Dae-Jun Kim, Hyun-Mo Ryu, Sang-in Park, Soo-Jin Park, Chang-Hyun Song & Sae-Kwang Ku. (2015) Pharmacokinetic Properties of Ondansetron in Combination with Ijintang-gamibang, Polyherbal Complex in Rats. International Journal of Pharmacology 11:4, pages 351-358.
Crossref
Bekkhan Bayalovich Khatsiev, Aleksandr Nikolaevich Kuzminov, Yuriy Ivanovich Yashkov & Nauruz Akhmatovich Uzdenov. (2014) Enhanced recovery after bariatric surgery – a modern approach. Obesity and metabolism 11:4, pages 19-24.
Crossref
Klaus Bielefeldt. (2012) Gastroparesis: Concepts, Controversies, and Challenges. Scientifica 2012, pages 1-19.
Crossref